NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Forecasted Federal grant Posted
- Opportunity number
- FOR-FD-25-014
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Applications expected due
- Not on record
- Award size
- Up to $4,500,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Food and Nutrition
- Agriculture
- Consumer Protection
- Eligible applicants
-
- Unrestricted
- For Profit Organizations
- Special District Governments
- Higher Education Inst. (Private)
- Independent School Districts
- Small Businesses
- City/Township Governments
- County Governments
- Tribal Organizations (Not Federally Recognized)
- State Governments
- 501(c)(3) Nonprofits
- Non-501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- Points of contact
-
- Terrin Brown terrin.brown@fda.hhs.gov (240) 402-7610
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Food and Drug Administration's Center for Veterinary Medicine is soliciting applications for cooperative agreements to strengthen antibiotic resistance surveillance in retail food specimens under the National Antimicrobial Resistance Monitoring System (NARMS), with no hard application deadline specified in this forecast announcement posted November 5, 2024.
Eligible applicants include unrestricted categories: for-profit organizations, small businesses, state and local governments, tribal governments (both federally recognized and not federally recognized), public and private higher education institutions, school districts, public or Indian housing authorities, and 501(c)(3) and non-501(c)(3) nonprofits.
The program builds on NARMS, initiated in 1996 as a key national action to combat antibiotic resistance. Cooperative agreements will enhance detection of antibiotic resistance among bacteria in food commodities and expand to new sampling sites to broaden program scope. Measurable outcomes must align with NARMS Objectives.
This opportunity falls under CFDA 93.103 (Food and Drug Administration Research). The parent program has sustained activity for 45 years, awarding 90 to 167 grants annually over the past five years. Recent awards under CFDA 93.103 have ranged from $50 thousand to $6.8 million depending on activity type, with state laboratory cooperative agreements ranging from $250 thousand to $2.4 million. The broader program portfolio reflects predominant use of cooperative agreements (58% of awards) and includes non-federal cost-share contributions across the funding base.
Cost share requirements and award ceiling, floor, and expected number of awards for this specific opportunity are not specified in the forecast announcement.
Forecast synopsis
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance monitoring in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity